Efficacy, safety, and tolerability of a triple reuptake inhibitor GSK372475 in the treatment of patients with major depressive disorder: two randomized, placebo- and active-controlled clinical trials

2011 ◽  
Vol 26 (5) ◽  
pp. 653-662 ◽  
Author(s):  
Susan Learned ◽  
Ole Graff ◽  
Suraja Roychowdhury ◽  
Rachel Moate ◽  
K Ranga Krishnan ◽  
...  
Keyword(s):  
Clinical Trials ◽  
Major Depressive Disorder ◽  
Depressive Disorder ◽  
Reuptake Inhibitor ◽  
Controlled Clinical Trials ◽  
Major Depressive

Safety and tolerability of duloxetine in the treatment of major depressive disorder: analysis of pooled data from eight placebo-controlled clinical trials

2005 ◽  
Vol 20 (5) ◽  
pp. 327-341 ◽  
Author(s):  
James I. Hudson ◽  
Madelaine M. Wohlreich ◽  
Daniel K. Kajdasz ◽  
Craig H. Mallinckrodt ◽  
John G. Watkin ◽  
...  
Keyword(s):  
Clinical Trials ◽  
Major Depressive Disorder ◽  
Depressive Disorder ◽  
Controlled Clinical Trials ◽  
Major Depressive ◽  
Pooled Data
Sign in / Sign up

Export Citation Format

Share Document